FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Akron Pharma OneLAX Docusate Sodium Liquid Recall

OneLAX Docusate Sodium Liquid (docusate sodium 50 mg/5 mL) Stool Softener Laxative, 16…

Akron Pharma, Inc. · Fairfield, NJ

Risk level
Class II
Reported by FDA
Oct 30, 2024
Recall ID
D-0025-2025
Check your lot numberHow we source this data

Summary

Akron Pharma recalled OneLAX Docusate Sodium Liquid starting Oct 15, 2024. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0025-2025 on Oct 30, 2024. Reason: CGMP Deviations. Status: Ongoing.

Why it was recalled

CGMP Deviations

Product description

OneLAX Docusate Sodium Liquid (docusate sodium 50 mg/5 mL) Stool Softener Laxative, 16 FL OZ (473 mL) bottle, Akron Pharma, Manufactured for: Akron Pharma, Inc., Fairfield, NJ 07004, NDC 71399-0039-06.

Lot numbers, UPCs & expiration codes

Lot #ODS230001A, ODS230002A, Exp. 10/2025; ODS230003A, Exp. 11/2025.

Where it was sold

Nationwide in the US

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0025-2025
Classification
Class II
Status
Ongoing
Recall initiated
Oct 15, 2024
FDA report date
Oct 30, 2024
Quantity
10845 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Akron Pharma, Inc.

Original FDA data

Every field from FDA enforcement report D-0025-2025, exactly as published.

Show all FDA fields
City
Fairfield
State
NJ
Status
Ongoing
Country
United States
Event ID
95511
Address
373 Us Highway 46 Ste 117
Code information
Lot #ODS230001A, ODS230002A, Exp. 10/2025; ODS230003A, Exp. 11/2025.
Postal code
07004-2456
Report date
Oct 30, 2024
Product type
Drugs
Recall number
D-0025-2025
Classification
Class II
Recalling firm
Akron Pharma, Inc.
Product quantity
10845 bottles
Reason for recall
CGMP Deviations
Voluntary / mandated
Voluntary: Firm initiated
Product description
OneLAX Docusate Sodium Liquid (docusate sodium 50 mg/5 mL) Stool Softener Laxative, 16 FL OZ (473 mL) bottle, Akron Pharma, Manufactured for: Akron Pharma, Inc., Fairfield, NJ 07004, NDC 71399-0039-06.
Distribution pattern
Nationwide in the US
Recall initiation date
Oct 15, 2024
Initial firm notification
Letter
Center classification date
Oct 24, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0025-2025, published Oct 30, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls